441
Participants
Start Date
March 15, 2022
Primary Completion Date
July 2, 2024
Study Completion Date
July 2, 2024
Rimegepant
rimegepant ODT 75mg daily
SPRI Clinical Trials, LLC, Brooklyn
Clinical Research Philadelphia, LLC, Philadelphia
Tidewater Integrated Medical Research, Virginia Beach
Phoenix Medical Research, LLC, Miami
WR-ClinSearch, LLC, Chattanooga
Velocity Clinical Research, Cincinnati
Michigan Head Pain & Neurological Institute, Ann Arbor
The Headache Clinic, Alexandria
OK Clinical Research, LLC, Edmond
VIP Trails, San Antonio
VIP Trials, San Antonio
Elite Clinical Studies, LLC, Phoenix
Advanced Investigative Medicine, Inc., Hawthorne
Velocity Clinical Research - North Hollywood, North Hollywood
Chase Medical Research, LLC, Waterbury
Boston Clinical Trials, Boston
CVS HealthHub - East Brunswick, East Brunswick
CVS HealthHub - Lawrenceville, Lawrenceville
CVS HealthHUB - Runnemede, Runnemede
Lead Sponsor
Pfizer
INDUSTRY